A surge in COVID-19 cases in US becomes an ominous sign for bulls at D-Street; RBI Governor tests positive
A surge in COVID-19 cases in US becomes an ominous sign for bulls at D-Street; RBI Governor tests positive

A surge in COVID-19 cases in US becomes an ominous sign for bulls at D-Street; RBI Governor tests positive

Karan Dsij Article rating: 4.8

Indian markets are likely to begin the week on a soft note as cues from the global peers are not supportive. In fact, the news of a resurge of Coronavirus cases in the West is throwing cold showers on the hopes of economic recovery.

Making sense with Capture ratio
Making sense with Capture ratio

Making sense with Capture ratio

Henil Shah Article rating: 5.0

When it comes to evaluating a mutual fund, there are a host of parameters available and Capture ratio is one of them. Read on to find out more.

Zydus Cadila obtains final USFDA nod for Albuterol tablets; stock up by 2 per cent
Zydus Cadila obtains final USFDA nod for Albuterol tablets; stock up by 2 per cent

Zydus Cadila obtains final USFDA nod for Albuterol tablets; stock up by 2 per cent

Anthony Fernandes Article rating: 4.4

Zydus Cadila informed the exchanges today that it has received final approval from United States Food & Drug Administration (USFDA) to market Albuterol tablets in the strengths of 2 mg and 4 mg, which is bioequivalent of reference listed drug (RLD) Proventil tablets.

RSS
First19501951195219531955195719581959Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR